JOSE MARIA EIROS BOUZA-rekin lankidetzan egindako argitalpenak (38)

2023

  1. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

2022

  1. Crispr/casrx proof-of-concept for rna degradation: A future tool against rna viruses?

    Pharmaceuticals, Vol. 15, Núm. 1

  2. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients

    Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240

  3. N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study

    Clinical Microbiology and Infection, Vol. 28, Núm. 10, pp. 1391.e1-1391.e5

  4. PCR-based diagnosis of respiratory virus in postsurgical septic patients: A preliminary study before SARS-CoV-2 pandemic

    Medicine (United States), Vol. 101, Núm. 32, pp. E29902

2021

  1. A new MALDI-TOF approach for the quick sequence type identification of Legionella pneumophila

    Journal of Microbiological Methods, Vol. 188

  2. Combining immunomodulators and antivirals for COVID-19 – Authors' reply

    The Lancet Microbe

  3. Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma

    European Journal of Clinical Investigation, Vol. 51, Núm. 6

  4. Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  5. GISAID: INICIATIVA INTERNACIONAL PARA COMPARTIR DATOS GENÓMICOS DEL VIRUS DE LA GRIPE Y DEL SARS-CoV-2

    Revista Espanola de Salud Publica, Vol. 95

  6. Mounting evidence of impaired viral control in severe COVID-19

    The Lancet Microbe

2020

  1. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

    Critical Care, Vol. 24, Núm. 1

2018

  1. Evolution of the incidence, mortality, and cost of infective endocarditis in Spain between 1997 and 2014

    Journal of General Internal Medicine, Vol. 33, Núm. 10, pp. 1610-1613

  2. Impact of an ultraviolet air sterilizer on cardiac surgery patients, a randomized clinical trial

    Medicina Clinica, Vol. 151, Núm. 8, pp. 299-307

2016

  1. Defining immunological dysfunction in sepsis: A requisite tool for precision medicine

    Journal of Infection, Vol. 72, Núm. 5, pp. 525-536

  2. Deletion of FAST (Fas-activated serine/threonine phosphoprotein) ameliorates immune complex arthritis in mice

    Modern Rheumatology, Vol. 26, Núm. 4, pp. 630-632

  3. Impact of ventilator-associated pneumonia on mortality and epidemiological features of patients with secondary peritonitis

    Annals of Intensive Care, Vol. 6, Núm. 1

  4. Postbooster antibodies from humans as source of diphtheria antitoxin

    Emerging Infectious Diseases, Vol. 22, Núm. 7, pp. 1265-1267

  5. Procalcitonin cannot be used as a biomarker of infection in heart surgery patients with acute kidney injury

    Journal of Critical Care, Vol. 33, pp. 233-239

2015

  1. Preventing sepsis

    The Lancet Infectious Diseases